Cargando…

Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer

BACKGROUND: Accessible biomarkers are needed for immunotherapy in advanced non-small-cell lung cancer (NSCLC). We previously described a multivariate risk prediction model, the iSEND, which categorises advanced NSCLC patients treated with nivolumab into Good, Intermediate or Poor groups. This model...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Wungki, Mezquita, Laura, Okabe, Naoyuki, Chae, Young Kwang, Kwon, Deukwoo, Saravia, Diana, Auclin, Edouard, Planchard, David, Caramella, Caroline, Ferrara, Roberto, Agte, Sarita, Oh, Michael, Mudad, Raja, Jahanzeb, Mohammad, Suzuki, Hiroyuki, Besse, Benjamin, Lopes, Gilberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000664/ https://www.ncbi.nlm.nih.gov/pubmed/31761899 http://dx.doi.org/10.1038/s41416-019-0643-y

Ejemplares similares

Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates
por: Meng, Qian-Fang, et al.
Publicado: (2023)

LIPI及iSEND免疫评分在晚期非小细胞肺癌免疫治疗中的预测价值分析
Publicado: (2022)

Comment on Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. Cancers 2021, 13, 1176
por: Auclin, Edouard, et al.
Publicado: (2021)

CD8(+)PD-1(+) to CD4(+)PD-1(+) ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers
por: Duchemann, Boris, et al.
Publicado: (2022)

Integrin-α(V)-mediated activation of TGF-β regulates anti-tumour CD8 T cell immunity and response to PD-1 blockade
por: Malenica, Ines, et al.
Publicado: (2021)

Impact of Intercurrent Introduction of Steroids on Clinical Outcomes in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients under Immune-Checkpoint Inhibitors (ICI)
por: De Giglio, Andrea, et al.
Publicado: (2020)

Chronic Plasma Exposure to Kinase Inhibitors in Patients with Oncogene-Addicted Non-Small Cell Lung Cancer
por: Geraud, Arthur, et al.
Publicado: (2020)

Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer
por: Schernberg, Antoine, et al.
Publicado: (2018)

Send It In
Publicado: (1917)

The Excised Appendix Tip—To Send or not to Send, That is the Question
por: Tullie, Lucinda, et al.
Publicado: (2018)

Predicting Immunotherapy Outcomes in Older Patients with Solid Tumors Using the LIPI Score
por: Pierro, Monica, et al.
Publicado: (2022)

Routine histological examination of epidermoid cysts; to send or not to send?
por: Apollos, Jeyakumar R., et al.
Publicado: (2016)

Send in the clowns
por: Vaughan, Sarah, 1924-
Publicado: (1981)

On Sending in Medicines
Publicado: (1811)

Send in the therapists?
por: The Lancet Psychiatry
Publicado: (2020)

Sending-or-not-sending twin-field quantum key distribution in practice
por: Yu, Zong-Wen, et al.
Publicado: (2019)

Establishment of the Global SEND Alliance (G-SEND) in Japan and efficient creation of electronic SEND datasets between CROs
por: Anzai, Takayuki, et al.
Publicado: (2019)

Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung Cancer
por: Duchemann, Boris, et al.
Publicado: (2020)

Robust twin-field quantum key distribution through sending or not sending
por: Jiang, Cong, et al.
Publicado: (2022)

Sending servers to Morocco
por: Joannah Caborn Wengler
Publicado: (2012)

Did You Send It?
por: Pagliaro, Mario
Publicado: (2019)

Sending retirees to the frontlines?
por: Sabath, Bruce F., et al.
Publicado: (2020)

Errors in Sending Bills
Publicado: (1859)

Sending Plants to Sleep
Publicado: (1877)

Mps1 sends condensin II off to work
por: Leslie, Mitch
Publicado: (2014)

Sending-or-Not-Sending Twin-Field Quantum Key Distribution with Light Source Monitoring
por: Qiao, Yucheng, et al.
Publicado: (2019)

Sending or Not-Sending Twin-Field Quantum Key Distribution with Flawed and Leaky Sources
por: Lu, Yi-Fei, et al.
Publicado: (2021)

Complete response to ipilimumab and nivolumab therapy in a patient with extensive extrapulmonary high-grade small cell carcinoma of the pancreas and HIV infection
por: Husnain, Muhammad, et al.
Publicado: (2018)

CD103(+)CD8(+) T(RM) Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17
por: Corgnac, Stéphanie, et al.
Publicado: (2020)

Passive Light Source Monitoring for Sending or Not Sending Twin-Field Quantum Key Distribution
por: Qian, Xuerui, et al.
Publicado: (2022)

Security Analysis of Sending or Not-Sending Twin-Field Quantum Key Distribution with Weak Randomness
por: Jiang, Xiao-Lei, et al.
Publicado: (2022)

Preparing to send beam to the SPS
Publicado: (1975)

Sending the advance party for metastases
por: Wells, William A.
Publicado: (2006)

BFA sends proteins back
por: Powell, Kendall
Publicado: (2006)

BDNF sends mixed signals
por: Short, Ben
Publicado: (2009)

Sending sisters their separate ways
por: Leslie, Mitch
Publicado: (2014)

Where to Send Christmas Boxes
Publicado: (1892)

Where to Send Our Students
Publicado: (1877)

Sending-or-Not-Sending Twin-Field Quantum Key Distribution with a Passive Decoy-State Method
por: Xue, Ke, et al.
Publicado: (2022)

Send for the police! : a crime story about the work of the british police
por: Wymer, Norman
Publicado: (1968)

Cannot write session to /tmp/vufind_sessions/sess_7pmsl7oq61ui0a7322ibjn3lqm